Ondansetron Tablet, Orally Disintegrating
Product Images NDC 80425-0222

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 80425-0222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description 1 (Description 1)

Description 1 (Description 1)
Chemical structure diagram of ondansetron, showing the arrangement of its molecular components including rings and bonds.*
FDA Label Image

Description (Description)

Description (Description)
Chemical structure of Ondansetron hydrochloride dihydrate, showing its molecular framework including indole and imidazole rings with methyl groups.*
FDA Label Image

Label 1 (Ondansetron Odt 80425 0222 01)

Label 1 (Ondansetron Odt 80425 0222 01)
Ondansetron Orally Disintegrating Tablet 8 mg packaging label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes dosage strength, storage instructions at 20-25°C (68-77°F), manufacturer Glenmark Pharma's information, and references to NDC codes and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.